Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

Saudi Arabia · Delayed Price · Currency is SAR

36.38

-0.38 (-1.03%)

Jul 2, 2026, 3:19 PM AST

-9.00% (1Y)

Market Cap	8.37B -8.7%
Revenue (ttm)	3.11B +10.7%
Net Income	256.39M -10.7%
EPS	1.11 -12.7%
Shares Out	230.00M
PE Ratio	32.64
Forward PE	27.68
Dividend	0.33 (0.91%)
Ex-Dividend Date	Jul 1, 2026

Volume	63,843
Open	36.76
Previous Close	36.76
Day's Range	36.14 - 37.00
52-Week Range	27.20 - 42.84
Beta	-0.17
Analysts	Hold
Price Target	41.02 (+12.75%)
Earnings Date	Aug 11, 2026

About TADAWUL:4017

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. The company operates through Medical Services; Education; and Trading, Retail & Others segments. It provides various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermat... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1978

Employees 2,672

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4017

Full Company Profile

Financial Performance

In 2025, TADAWUL:4017's revenue was 3.09 billion, an increase of 10.73% compared to the previous year's 2.79 billion. Earnings were 290.18 million, an increase of 0.91%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 4017 stock is "Hold." The 12-month stock price target is SAR 41.02, which is an increase of 12.75% from the latest price.

Price Target

SAR 41.02

(12.75% upside)

Analyst Consensus: Hold

Stock Forecasts